drug
IFOSFAMIDE
Marketedupdated 6mo agoby Baxter Healthcare Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(4)
Trials studying IFOSFAMIDE
- phase2Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)
- phase2Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- phase2A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
- phase3Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
- phase1Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors
- phase1Study of Oral Palifosfamide Tris in Solid Tumors
- phase1Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
- phase2Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that